TanshinonellA phenanthroimidazole derivative polarizes macrophage to improve metabolic homeostasis
TanshinonellA phenanthroimidazole derivative polarizes macrophage to improve metabolic homeostasis
复制标题
丹参酮 — 一种菲咪唑衍生物,可使巨噬细胞极化,改善代谢稳态
DOI:
10.1016/j.bbrc.2019.05.056
复制
发表时间:
2019
影响因子:
3.1
通讯作者:
Yang Zhonghan
中科院分区:
文献类型:
--
作者:
Ma Lei;Luo Shiya;Zhou Lin;Zhao Zewei;Li Qiao;Xu Lin;Gong Baoyong;Qi Weiwei;Zhou Ti;Yang Xia;Gao Guoquan;Mei Wenjie;Yang Zhonghan
Macrophages infiltrated in adipose tissue play a key role in obesity. Some traditional pharmaceutical compounds may shift the polarization of recruited macrophages to improve metabolic homeostasis. TanshinoneⅡA (TAN2A) is a major active component ofSalvia miltiorrhiza,a traditional anti-inflammatory cardiovascular medicine. In our study, we firstly constructed a phenanthroimidazole derivative of TAN2A named TAN20 by chemical synthesis, then identified its structure by chromatography and hydrogen spectroscopy, and finally examined its effects on immunometabolic responses. We found that TAN20 significantly induced the alternatively-activated (M2) rather than the classically-activated macrophages (M1), mainly through releasing the type II cytokines. Such effects were more pronounced than that from TAN2A. Compared to TAN2A, TAN20 substantially reduced body weight, decreased serum free fatty acid and HOMA-IR, and increased insulin sensitivity in obesity-induced diabetic mice. These effects of TAN20 were further validated on diabetic cynomolgus monkeys, which are closer to human physiological conditions. Taken together, our findings explicitly showed that TAN20 significantly polarized the macrophage and improved metabolic homeostasis in obesity-induced diabetic models, suggesting that TAN20 may be a potential drug against diabetes and obesity.